Brief: Imricor Medical Systems Granted ASX Waiver From Listing Rules Effective 26 May
27/05/2026 02:23
BRIEF-Imricor Medical Systems Granted ASX Waiver From Listing Rules Effective 26 May May 27 (Reuters) - Imricor Medical Systems Inc IMR.AX:
GRANTING OF ASX WAIVER - US FINANCIAL REPORTING REQUIREMENTS
GRANTED ASX WAIVER FROM LISTING RULES EFFECTIVE 26 MAY 2026
WAIVER ALIGNS IMRICOR ASX REPORTING WITH U.S. REQUIREMENTS
Further company coverage: IMR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imricor Medical Systems,
See all newsBrief: Imricor Medical Systems, Inc Submits Third PMA Module To The US FDA For Review
Brief: Imricor Medical Systems Granted ASX Waiver From Listing Rules Effective 26 May
Australia's Imricor Medical Systems slips on discounted placement
Brief: Imricor Medical Systems To Raise A$60 Mln At A$1.85 Per Share
Australia's Imricor rises on seeking FDA nod for product expansion in U.S.